| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Clinical and experimental thyroidology |
2021―Mar―18 |
Translation of the ESE statement concerning COVID-19 vaccination sent to all Presidents of the ESE Council of Affiliated Societies |
Article Editorial |
| 2 |
[GO] |
Obesity and metabolism |
2021―Mar―06 |
Peculiarities of the COVID-19 course and consequences in overweight and obese patients. Lessons from the current pandemic |
T. Yu. Demidova, E. I. Volkova, E. Yu. Gritskevich |
| 3 |
[GO] |
Diabetes Mellitus |
2021―Feb―15 |
Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease |
E. M. Zeltyn-Abramov, M. A. Lysenko, N. F. Frolova, T. N. Markova, N. I. Belavina, N. N. Klochkova, et al. (+3) S. V. Kondrashkina, R. T. Iskhakov, A. I. Ushakova |
| 4 |
[GO] |
Diabetes Mellitus |
2021―Feb―15 |
High level of glycated hemoglobin (HbA1c) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus |
M. V. Shestakova, I. V. Kononenko, Z. A. Kalmykova, A. V. Zheleznyakova, N. G. Mokrysheva |
| 5 |
[GO] |
Problems of Endocrinology |
2020―Dec―08 |
The role of HLA genes: from autoimmune diseases to COVID-19 |
Ekaterina A. Troshina, Marina Yu. Yukina, Nurana F. Nuralieva, Natalia G. Mokrysheva |
| 6 |
[GO] |
Problems of Endocrinology |
2020―Dec―08 |
Androgens and Antiandrogens influence on COVID-19 disease in men |
Roman V. Rozhivanov, Elena N. Andreeva, Galina A. Melnichenko, Natalya G. Mokrysheva |
| 7 |
[GO] |
Clinical and experimental thyroidology |
2020―Nov―30 |
Adaptation of the hypothalamo-pituitary-thyroid and hypothalamo-pituitary-adrenal systems to a new infectious disease - COVID-19 in the development of COVID-19 pneumonia and/or cytokine storm |
Ekaterina Troshina, Galina Melnichenko, Evgeniya Senyushkina, Natalia Mokrysheva |
| 8 |
[GO] |
Problems of Endocrinology |
2020―Sep―16 |
Screening for gestational diabetes due to of the COVID-19 pandemic |
Ayarpi O. Torosyan, Ekaterina V. Loginova, Chelebi G. Gagaev |
| 9 |
[GO] |
Diabetes Mellitus |
2020―Aug―10 |
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
Z. A. Kalmykova, I. V. Kononenko, I. A. Sklyanik, M. V. Shestakova, N. G. Mokrysheva |
| 10 |
[GO] |
Diabetes Mellitus |
2020―Aug―10 |
COVID-19 and kidneys |
M. S. Shamkhalova, N. G. Mokrysheva, M. V. Shestakova |
| 11 |
[GO] |
Diabetes Mellitus |
2020―Aug―10 |
The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus |
O. K. Vikulova, Zamira Zuraeva, L. V. Nikankina, M. V. Shestakova |
| 12 |
[GO] |
Diabetes Mellitus |
2020―Jun―27 |
Course and treatment of diabetes mellitus in the context of COVID-19 |
Marina V. Shestakova, Natalya G. Mokrysheva, Ivan I. Dedov |
| 13 |
[GO] |
Problems of Endocrinology |
2020―Jun―07 |
Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the Russian Diabetes Registry. |
Marina V Shesnakova Shtsnakova, Vikulova Vikulova, Mikhail Isakov, Ivan Dedov |
| 14 |
[GO] |
Problems of Endocrinology |
2020―May―09 |
COVID-19 pandemic and endocrinopathies. |
Natalia G. Mokrysheva, Gagik R. Galstyan, Michael A. Kirzhakov, Anna K. Eremkina, Galina A. Melnichenko |
